99mTc-MIBI scintimammography and digital mammography in the diagnosis of multicentric breast cancer

OBJECTIVETo compare diagnostic accuracy of scintimammography (SMG) and digital mammography (DS) in the diagnosis of multicentric breast cancer. SUBJECTS AND METHODSThree hundred and sixty seven women with histologically confirmed breast cancer were included in this analysis. All patients were candid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hellenic journal of nuclear medicine 2019-09, Vol.22 (3), p.172-178
Hauptverfasser: Novikov, Sergey Nikolaevich, Chernaya, Antonina Viktorovna, Krzhivitsky, Pavel Ivanovich, Kanaev, Sergey Vasilevich, Krivorotko, Petr Vladimirovich, Artemyeva, Anna Sergeevna, Popova, Nadezhda Sergeevna
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVETo compare diagnostic accuracy of scintimammography (SMG) and digital mammography (DS) in the diagnosis of multicentric breast cancer. SUBJECTS AND METHODSThree hundred and sixty seven women with histologically confirmed breast cancer were included in this analysis. All patients were candidates for conservative breast surgery and had cT1-3N0-1 stage of disease. Scintimammography was performed in prone position 5-10min after intravenous injection of 740MBq of technetium-99m-methoxy-isobtyl-isonitrile (99mTc-MIBI) with acquisition time of 10min for every lateral and anterior projection. Digital mammography was done in all women according to a standard clinical protocol. Final diagnosis was established by histopathology. Multicentric breast cancer was defined as 2 or more distinct invasive tumors located in more than one quadrant or additional lesions from the primary tumor of more than 4cm in size. RESULTSAccording to histopathological examinations multicentric breast cancer was diagnosed in 47 of 367 (12.8%) patients. Scintimammography was more effective than mammography in detecting multicentric breast cancer: sensitivity: 83.0% vs 40.4% (P
ISSN:1790-5427
DOI:10.1967/s002449911052